Advertisement

EB Virus-Induced Antigens

  • I. Ernberg
  • G. Klein

Abstract

The study of antigenic markers and antibodies directed against them has occupied a central position in all Epstein-Barr virus (EBV) research, ever since the discovery of the virus. Detailed seroepidemiologic studies on the distribution and pathogenic significance of virus infections, retrospective and prognostic studies on patients with EBV-related diseases, and tracing of early events during primary viral infection of normal cells in vitro are only some of the areas that were largely or entirely based on antigen-antibody tests. Serology played a primary role in establishing the relationship between the virus and the three EBV-related diseases: infectious mononucleosis (IM), Burkitt’s lymphoma (BL), and nasopharyngeal carcinoma (NPC). Furthermore, the majority of viral infectivity assays are based on antigen induction in appropriate target cells.

Keywords

Nuclear Antigen Raji Cell Early Antigen Viral Capsid Antigen Viral Cycle 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Armstrong, D., Henle, G., Henle, W.: Complement fixation tests with cell lines derived from Burkitt’s lymphoma and acute leukemias. J. Bacteriol. 91, 1257–1262 (1966)PubMedGoogle Scholar
  2. Aya, T., Osato, T.: Early events in transformation of human cord leukocytes by Epstein-Barr virus: Induction of DNA-synthesis, mitosis and virus associated nuclear antigen synthesis. Int. J. Cancer 14, 341–347 (1974)PubMedGoogle Scholar
  3. Bahr, G. F., Mikel, U., Klein, G.: Localization and quantitation of EBV-associated nuclear antigen (EBNA) in Raji cells. Beitr. Pathol. 155, 72–78 (1975)PubMedGoogle Scholar
  4. Bakacs, T., Svedmyr, E., Klein, E., Rombo, L., Weiland, O.: EBV-related cytotoxicity of Fc-receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients. Cancer Letters, 4, 185–189 (1978)PubMedGoogle Scholar
  5. Baron, D., Strominger, J.: Partial purification and properties of the Epstein-Barr virus associated nuclear antigen, J. Biol. Chem. 253, 2875–2881 (1978)PubMedGoogle Scholar
  6. Baron, D., Benz, W. C., Carmichael, G., Yocum, R. R., Strominger, J. L.: Assay and partial purification of Epstein-Barr virus nuclear antigen. In: Epstein-Barr virus production, concentration and purification. IARC Internal Technical Report 75/003. pp. 257–262. Lyon: IARC 1975Google Scholar
  7. Becker, Y., Weinberg, A.: Molecular events in the biosynthesis of Epstein-Barr virus in Burkitt lymphoblasts. In: Oncogenesis and herpesviruses. Biggs, P. M., de-Thé, G., Payne, L. N. (eds.), pp. 326–335. Lyon: IARC 1972Google Scholar
  8. Ber, R., Klein, G., Moar, M., Povey, S., Rosen, A., Westman, A., Yefenof, E., Zeuthen, J.: Somatic cell hybrids between human lymphoma lines. IV. Establishment and characterization of a P3HR-1/Daudi hybrid. Int. J. Cancer 21, 701–719 (1978)Google Scholar
  9. Brown, T. D. K., Ernberg, I., Lamon, E. W., Klein, G.: Detection of Epstein-Barr virus (EBV)-associated nuclear antigen in human lymphoblastoid cell lines by means of an I125-IgG binding assay. Int. J. Cancer 13, 785–794 (1974)PubMedGoogle Scholar
  10. Brown, T. D. K., Ernberg, I., Klein, G.: Studies of Epstein-Barr virus (EBV)-associated nuclear antigen. I. Assay in human lymphoblastoid cell lines by direct and indirect determination of I125-IgG binding. Int. J. Cancer 15, 606–616 (1975)PubMedGoogle Scholar
  11. Brugge, J. S., Butel, J. S.: Role of Simian virus 40 gene: A function in maintenance of transformation. J. Virol. 15, 619–635 (1975)PubMedGoogle Scholar
  12. Dalianis, T., Klein, G., Andersson, B.: Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line. Int. J. Cancer 19, 460–467 (1977)PubMedGoogle Scholar
  13. Demissie, A.: Difference in heat stability of antigens associated with Epstein-Barr virus, demonstrated by immunodiffusion. J. Natl. Cancer Inst. 51, 751–760 (1973)PubMedGoogle Scholar
  14. Demissie, A., Svedmyr, A.: Difference in heat stability of antigens associated with Epstein-Barr virus, demonstrated by immunofluorescence. J. Natl. Cancer Inst. 50, 63–67 (1973)PubMedGoogle Scholar
  15. De Schryver, A., Klein, G., Hewetson, J., Rocchi, G., Henle, W., Henle, G., Moss, D. J., Pope, J. H.: Comparison of EBV-neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA). Int. J. Cancer 13, 353–362 (1974)PubMedGoogle Scholar
  16. Dölken, G., Klein, G.: Expression of Epstein-Barr virus (EBV) associated membrane antigen (MA) in Raji cells superinfected with two different virus strains. Virology 70, 210–213 (1976)PubMedGoogle Scholar
  17. Dölken, G., Klein, G.: A solid phase radioimmunoassay for Epstein-Barr virus associated membrane antigen prepared from B95–8 cell culture supernatants. J. Natl. Cancer Inst. 58, 1239–1245 (1977 a)PubMedGoogle Scholar
  18. Dölken, G., Klein, G.: Radioimmunoassay for Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA). Binding of iodinated antibodies to antigens immobilized in Polyacrylamide gel. Eur. J. Cancer 13, 1277–1286 (1977b)PubMedGoogle Scholar
  19. Dolyniuk, M., Pritchett, R., Kieff, E.: Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. J. Virol. 17, 935–949 (1976 a)PubMedGoogle Scholar
  20. Dolyniuk, M., Wolff, E., Kieff, E.: Proteins of Epstein-Barr virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing components of enveloped virus. J. Virol. 18, 269–287 (1976b)Google Scholar
  21. Durr, F. E., Monroe, J. H., Schmitter, R., Traul, K. A., Hirshaut, Y.: Studies on the infectivity and cytopathology of Epstein-Barr virus in human lymphoblastoid cells. Int. J. Cancer 6, 436–449 (1970)PubMedGoogle Scholar
  22. Einhorn, L., Ernberg, I.: Induction of EBNA precedes stimulation of DNA-synthesis in EBV-infected human-lymphocytes. Int. J. Cancer 21, 157–160 (1978)PubMedGoogle Scholar
  23. Epstein, M.A., Achong, B. G.: Specific immunofluorescence test for the herpes-type EB virus of Burkitt lymphoblasts, authenticated by electron microscopy. J. Natl. Cancer Inst. 40, 593–603 (1968)PubMedGoogle Scholar
  24. Epstein, M. A., Achong, B. G., Barr, Y. M.: Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964 I, 702–703Google Scholar
  25. Ernberg, I., Brown, T. D. K.: Studies on the Epstein-Barr virus associated early antigen (EA) with I125-labeled IgG. In: Oncogenesis and Herpesviruses II. de-Thé, G., Epstein, M. A., zur Hausen, H. (eds.), Part 1, pp. 339–344. Lyon: IARC, 1975Google Scholar
  26. Ernberg, I., Klein, G., Kourilsky, F. M., Silvestre, D.: Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence. J. Natl. Cancer Inst. 53, 61–65 (1974)PubMedGoogle Scholar
  27. Ernberg, I., Masucci, G., Klein, G.: Persistance of Epstein-Barr viral nuclear antigen (EBNA) in cells entering the EB viral cycle. Int. J. Cancer 17, 197–203 (1976)Google Scholar
  28. Ernberg, I., Killander, D., Andersson-Anvret, M., Klein, G., Lundin, L.: Relationship between the amount of Epstein-Barr virus (EBV) determined nuclear antigen (EBNA)/cell and the number of EBV-DNA copies. Nature 266, 269–271 (1977)PubMedGoogle Scholar
  29. Ernberg, I., Killander, D., Lundin, L.: Quantity of Epstein-Barr viral nuclear antigen (EBNA) during different phases of the cell cycle. (Submitted for publication) (1978)Google Scholar
  30. Gerber, P.: Activation of Epstein-Barr virus by 5-bromodeoxyuridine “virus-free” free human cells. Proc. Natl. Acad. Sci. USA 69, 83–85 (1972)PubMedGoogle Scholar
  31. Gerber, P., Birch, S. M.: Complement-fixing antibodies in sera of human and non-human primates to viral antigen derived from Burkitt’s lymphoma cells. Proc. Natl. Acad. Sci. USA 58, 478–484 (1967)PubMedGoogle Scholar
  32. Gerber, P., Deal, D. R.: Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures. Proc. Soc. Exp. Biol. Med. 134, 748–751 (1970)PubMedGoogle Scholar
  33. Gergely, L., Klein, G., Ernberg, I.: Appearance of Epstein-Barr virus associated antigens in infected Raji cells. Virology 45, 10–21 (1971a)PubMedGoogle Scholar
  34. Gergely, L., Klein, G., Ernberg, I.: Effect of EBV-induced early antigens on host-cell macromolecular synthesis, studied by combined immunofluorescence and radioautography. Virology 45, 22–29 (1971 b)PubMedGoogle Scholar
  35. Gergely, L., Klein, G., Ernberg, I.: The action of DNA-antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines. Int. J. Cancer 7, 293–302 (1971 c)PubMedGoogle Scholar
  36. Hampar, B., Derge, J. G., Martos, L. M., Walker, J. L.: Synthesis of Epstein-Barr virus after activation of the viral genome in a virus negative human lymphoblastoid cell (Raji) made resistant to bromode-oxyuridine. Proc. Natl. Acad. Sci. USA 69, 78–82 (1972)PubMedGoogle Scholar
  37. Hampar, B., Derge, J. G., Nonoyama, M., Chang, S.-Y., Tagamets, M., Showalter, S. D.: Programming of events in Epstein-Barr virus activated cells induced by 5-iododeoxyuridine, Virology 62, 71–89, (1974)PubMedGoogle Scholar
  38. Hampar, B., Lenoir, G., Nonoyama, M., Derge, J. G., Chang, S. Y.: Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine. Virology 69, 660–668 (1976)PubMedGoogle Scholar
  39. Henle, G., Henle, W.: Immunofluorescence in cells derived from Burkitt’s lymphoma. J. Bacteriol. 91, 1248–1256 (1966)PubMedGoogle Scholar
  40. Henle, W., Henle, G.: Effect of arginine-deficient media on the herpes-type virus associated with cultured Burkitt tumor cells. J. Virol. 2, 182–191 (1968)PubMedGoogle Scholar
  41. Henle, W., Hummeler, K., Henle, G.: Antibody coating and agglutination of virus particles separated from the EB-3 line of Burkitt lymphoma cells. J. Bacteriol. 92, 269–271 (1966)PubMedGoogle Scholar
  42. Henle, W., Henle, G., Zajac, B., Pearson, G., Waubke, R., Scriba, M.: Differential reactivity of human sera with early antigens induced by Epstein-Barr virus. Science 169, 188–190 (1970)PubMedGoogle Scholar
  43. Henle, G., Henle, W., Klein, G.: Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus infected cells. Int. J. Cancer 8, 272–282 (1971)PubMedGoogle Scholar
  44. Hinuma, Y., Grace, J. T.: Cloning of immunoglobulin-producing human leukemic and lymphoma cells in long term cultures. Proc. Soc. Exp. Biol. Med. 124, 107–111 (1967)PubMedGoogle Scholar
  45. Hinuma, Y., Ohta, R., Miyamoto, T., Ishida, N.: Evaluation of the complement method of fluorescent antibody technique with myxoviruses. J. Immunol. 89, 19–26 (1962)PubMedGoogle Scholar
  46. Hinuma, Y., Konn, M., Yamaguchi, J.: Immunofluorescence and herpes type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1, 1045–1051 (1967)PubMedGoogle Scholar
  47. Huang, D. P., Ho, J. H. C., Henle, W., Henle, G.: Demonstration of Epstein-Barr virus associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies. Int. J. Cancer 14, 580–588 (1974)PubMedGoogle Scholar
  48. Inoue, M., Klein, G.: Reactivity of radioiodinated serum antibody from Burkitt’s lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Burkitt’s lymphoma. Clin. Exp. Immunol. 7, 39–50 (1970)PubMedGoogle Scholar
  49. Jehn, U., Lindahl, T., Klein, G.: Fate of virus DNA in the abortive infection of human lymphoid cell lines by Epstein-Barr virus. J. Gen. Virol. 16, 409–412 (1972)PubMedGoogle Scholar
  50. Jessel, D., Hudson, J., Landan, T., Livingston, D. M.: Interaction of partially purified Simian virus 40 T antigen with circular viral DNA molecules. Proc. Natl. Acad. Sci. USA 72, 1960–1964 (1975)PubMedGoogle Scholar
  51. Jondal, M., Svedmyr, E., Klein, E., Singh, S.: Killer T cells in a Burkitt’s lymphoma biopsy. Nature 255, 405–407 (1975)PubMedGoogle Scholar
  52. Klein, E., Klein, G., Nadkarni, J. S., Nadkarni, J. J., Wigzell, H., Clifford, P.: Surface IgM kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res. 28, 1300–1310 (1968)PubMedGoogle Scholar
  53. Klein, E., Becker, S., Svedmyr, E., Jondal, M., Vanky, F.: Tumor infiltrating lymphocytes. Ann. NY Acad. Sci. 276, 207–216 (1976b)PubMedGoogle Scholar
  54. Klein, G., Dombos, L.: Relationship between the sensitivity of EBV-carrying lymphoblastoid line to superinfection and the inducibiltiy of the resident viral genome. Int. J. Cancer 11, 327–337 (1973)PubMedGoogle Scholar
  55. Klein, G., Vonka, V.: Brief communication: Relationship between Epstein-Barr virus determined complement-fixing antigen and nuclear antigen detected by anti-complement fluorescence. J. Natl. Cancer Inst. 53, 1645–1646 (1974)PubMedGoogle Scholar
  56. Klein, G., Clifford, P., Klein, E., Stjernswärd, J.: Search for tumor specific immune reactions in Burkitt lymphoma patients by the membrane immunofluorescence reaction. Proc. Natl. Acad. Sci. USA 55, 1628–1635 (1966)PubMedGoogle Scholar
  57. Klein, G., Clifford, P., Klein, E., Stjernswärd, J.: Membrane immunofluorescence reactions of Burkitt’s lymphoma cells from biopsy specimens and tissue culture. J. Natl. Cancer Inst. 39, 1027–1044 (1967)PubMedGoogle Scholar
  58. Klein, G., Pearson, G., Nadkarni, J. S., Nadkarni, J. J., Klein, E., Henle, G., Henle, W., Clifford, P.: Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus. J. Exp. Med. 128, 1011–1020(1968)PubMedGoogle Scholar
  59. Klein, G., Pearson, G., Henle, G., Henle, W., Goldstein, G., Clifford, P.: Relation between Epstein-Barr virus and cell membrane immunofluorescence in Burkitt tumor cells. III. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera. J. Exp. Med. 129, 697–706 (1969)PubMedGoogle Scholar
  60. Klein, G., Gergely, L., Goldstein, G.: Two colour immunofluorescence studies on EBV determined antigens. Clin. Exp. Immunol. 8, 593–602 (1971)PubMedGoogle Scholar
  61. Klein, G., Giovanella, B. C., Lindahl, T., Fialkow, P. J., Singh, S., Stehlin, J. S.: Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc. Natl. Acad. Sci. USA 71, 4737–4741 (1974)PubMedGoogle Scholar
  62. Klein, G., Giovanella, B., Westman, A., Stehlin, J. S., Mumford, D.: An EBV-genome-negative cell line established from an American Burkitt lymphoma. Receptor characteristics, EBV infeetability and permanent conversion into EBV positive sublines by in vitro infection. Intervirology 5, 319–334 (1975)PubMedGoogle Scholar
  63. Klein, G., Svedmyr, E., Jondal, M., Persson, P. O.: EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients. Int. J. Cancer 17, 21–26 (1976 a)PubMedGoogle Scholar
  64. Klein, G., Clements, G., Zeuthen, J., Westman, A.: Somatic cell hybrids between human lymphoid lines. II. Spontaneous and induced pattern of the Epstein-Barr virus (EBV) cycle. Int. J. Cancer 17, 715–724 (1976 c)PubMedGoogle Scholar
  65. Klein, G., Yefenof, E., Falk, K., Westman, A.: Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt’s lymphoma. Int. J. Cancer 21, 552–560 (1978)PubMedGoogle Scholar
  66. Konn, M., Yohn, D. S., Hinuma, Y., Yamaguchi, J., Grace, J. T. (Jr.): Immunogel diffusion studies with the herpes type virus (HTV) associated with Burkitt’s lymphoma. Cancer Res. 27, 2532–2534 (1967)Google Scholar
  67. Lamon, E., Ernberg, I., Klein, G.: Detection of antigens determined by the Epstein-Barr virus (EBV) in human lymphoblastoid cell culture lines by elution of specific radioiodine labeled antibody. Clin. Immunol. Immunopathol. 2, 216–233 (1974a)PubMedGoogle Scholar
  68. Lamon, E., Ernberg, I., Klein, G.: Differential expression of Epstein-Barr virus early and membrane antigens after induction or superinfection. Cancer Biochem. Biophys. 1, 33–38 (1974b)Google Scholar
  69. Lenoir, G., Berthelon, M.-C., Favre, M.-C., de-Thé, G.: Characterization of Epstein-Barr virus antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with Epstein-Barr virus-associated nuclear antigen. J. Virol. 17, 672–674 (1976)PubMedGoogle Scholar
  70. Liabeuf, A., Nelson, K. A., Kourilsky, F. M.: The detection of the Epstein-Barr virus (EBV) nuclear antigen (EBNA) by anticomplement immunofluorescence. Immunoglobulin class of antibodies and role of complement. Int. J. Cancer 15, 533–546 (1975)PubMedGoogle Scholar
  71. Lindahl, T., Klein, G., Reedman, B., Johansson, B., Singh, S.: Relationship between Epstein-Barr virus (EBV)-DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative diseases. Int. J. Cancer 13, 764–772 (1974)PubMedGoogle Scholar
  72. Luka, J., Siegert, W., Klein, G.: Solubilization of the Epstein-Barr virus determined nuclear antigen and its characterization as a DNA-binding protein. J. Virol. 22, 1–8 (1977)PubMedGoogle Scholar
  73. Luka, J., Klein, G., Henle, W., Henle, G.: Detection of the EBV-determined nuclear antigen (EBNA) in Burkitt’s lymphoma and nasopharyngeal carcinoma biopsies by the acid fixed nuclear binding (AFNB) technique. Cancer Letters 4, 199–205 (1978 a)PubMedGoogle Scholar
  74. Luka, J., Lindahl, T., Klein, G.: Purification of the EB-virus determined nuclear antigen (EBNA) from EB-virus-transformed human lymphoid cell lines. J. Virol. 27, 604–611 (1978 b)PubMedGoogle Scholar
  75. Martin, R. G., Chou, J. Y.: Simian virus 40 functions required for the establishment and maintenance of malignant transformation. J. Virol. 15, 599–612 (1975)PubMedGoogle Scholar
  76. Matsuo, T., Nishi, S., Hirai, H., Osato, T.: Studies on Epstein-Barr virus related antigens. I. Indirect single radial immunodiffusion as a useful method for detection and assay of soluble antigen. Int. J. Cancer 18, 453–457 (1976)PubMedGoogle Scholar
  77. Matsuo, T., Nishi, S., Hirai, H., Osato, T.: Studies on Epstein-Barr virus related antigens. II. Biochemical properties of soluble antigen in Raji Burkitt lymphoma cells. Int. J. Cancer (in press) (1978)Google Scholar
  78. Mayyasi, S. A., Schidlovsky, G., Bulfone, L., Buschek, F. T.: The coating reaction of the herpes-type virus isolated from malignant tissues with an antibody present in sera. Cancer Res. 27, 2020–2024 (1967)PubMedGoogle Scholar
  79. Menezes, J., Leibold, W., Klein, G.: Biological differences between Epstein-Barr virus (EBV) strains with regard to lymphocyte transforming ability, superinfection and antigen induction. Exp. Cell Res. 92, 478–484 (1974)Google Scholar
  80. Menezes, J., Jondal, M., Leibold, W., Dorval, G.: Epstein-Barr vims interaction with human lymphocyte subpopulations: virus adsorption, kinetics of expression of EBV-associated nuclear antigen (EBNA) and lymphocyte transformation. Infect. Immun. 13, 303–310 (1976)PubMedGoogle Scholar
  81. Miller, G., Lipman, M.: Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70, 190–194 (1973)PubMedGoogle Scholar
  82. Moar, M., Siegert, W., Klein, G.: Detection and localization of Epstein-Barr virus-associated early antigens in single cell by autoradiography using I125 labeled antibodies. Intervirology 8, 226–239 (1977)PubMedGoogle Scholar
  83. Moar, M., Siegert, W., Klein, G.: Autoradiographic detection of Epstein-Barr virus (EBV) associated early antigen (EA) in a variety of EBV-DNA containing lymphoblastoid cell lines previously designated as non-producers. Intervirology 9, 333–343 (1978 a)PubMedGoogle Scholar
  84. Moar, M., Klein, G., Dölken, G.: Detection of the Epstein-Barr virus (EBV)-determined viral capsid antigen (VCA) by autoradiography in situ using I125-labeled antibodies, (Submitted for publication) (1978b)Google Scholar
  85. Nagoya, T., Hinuma, Y.: Production of infective Epstein-Barr virus in a Burkitt lymphoma cell line, P3HR-I. Gann 63, 87–93 (1972)PubMedGoogle Scholar
  86. Nyormoi, O., Klein, G., Adams, A., Dombos, L.: Sensitivity to EBV superinfection and IUDR inducibility of hybrid cells formed between a sensitive and a relatively resistant Burkitt lymphoma cell line. Int. J. Cancer 12, 396–408 (1973)PubMedGoogle Scholar
  87. Ohno, S., Luka, J., Falk, L., Klein, G.: Detection of a nuclear, EBNA type antigen in apparently EBNA-negative Herpesvirus papio (HVP)-transformed lymphoid lines by the acid-fixed nuclear binding technique. Int. J. Cancer 20, 941–946 (1977 a)PubMedGoogle Scholar
  88. Ohno, S., Luka, J., Lindahl, T., Klein, G.: Identification of a purified complement fixing antigen as the Epstein-Barr virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proc. Natl. Acad. Sci. USA 74, 1605–1609 (1977b)PubMedGoogle Scholar
  89. Ogburn, C. A., Zajac, B. A.: Detection of Epstein-Barr virus early antigen D and its antibodies by passive haemagglutination. Int. J. Cancer 19, 150–160 (1977)PubMedGoogle Scholar
  90. Old, L. J., Boyse, E. A., Oettgen, H. E., de Harven, E., Geering, G., Williamson, B., Clifford, P.: Precipitating antibodies in human serum to an antigen present in cultured Burkitt’s lymphoma cells. Proc. Natl. Acad. Sci. USA 56, 1699–1704 (1966)PubMedGoogle Scholar
  91. Osborn, M., Weber, K.: Simian virus 40 gene A function and maintenance of transformation. J. Virol. 15, 636–644 (1975)PubMedGoogle Scholar
  92. Pearson, G., Dewey, F., Klein, G., Henle, G., Henle, W., Relation between neutralization of Epstein-Barr virus and antibodies to cell membrane antigens induced by the virus. J. Natl. Cancer Inst. 45, 989–997 (1970)PubMedGoogle Scholar
  93. Pearson, G. R., Orr, T. W.: Antibody dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens. J. Natl. Cancer Inst. 56, 485–488 (1976)PubMedGoogle Scholar
  94. Pearson, G., Johansson, B., Klein, G.: Antibody dependent cellular cytotoxicity against Epstein-Barr virus-associated antigens in African patients with nasopharyngeal carcinoma. Int. J. Cancer 22, 120–125 (1978)PubMedGoogle Scholar
  95. Pope, J. H., Inoue, M. K., Wetters, E. J.: Significance of a complement-fixing antigen associated with herpes-like virus and detected in the Raji cell line. Nature 222, 166–167 (1969)Google Scholar
  96. Pulvertaft, R. J. V.: A study of malignant tumours in Nigeria in short term tissue culture. J. Clin. Pathol. 18, 261–273 (1965)PubMedGoogle Scholar
  97. Reed, S. I., Ferguson, J., Davis, R. W., Stark, G. R.: T antigen binds to Simian virus 40 DNA at the origin of replication. Proc. Natl. Acad. Sci. USA 72, 1605–1609 (1975)PubMedGoogle Scholar
  98. Reedman, B. M., Klein, G.: Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11, 599–620 (1973)Google Scholar
  99. Reedman, B. M., Pope, J. M., Moss, D. J.: Identity of the soluble EBV-associated antigens of tumor lymphoid cell lines. Int. J. Cancer 9, 172–181 (1972)PubMedGoogle Scholar
  100. Reedman, B. M., Klein, G., Pope, J. H., Walters, M. K., Hilgers, J., Singh, S., Johansson, B.: Epstein-Barr virus associated complement-fixing and nuclear antigens in Burkitt’s lymphoma biopsies. Int. J. Cancer 13, 755–763 (1974)PubMedGoogle Scholar
  101. Rickinson, A. B., Crawford, D., Epstein, M. A.: Inhibition of the in vitro outgrowth of Epstein-Barr virus-transformed lymphocytes by thymus-dependent lymphocytes from infectious mononucleosis patients. Clin. Exp. Immunol. 28, 72–79 (1977)PubMedGoogle Scholar
  102. Sairenji, T., Hinuma, Y.: Ultraviolet inactivation of Epstein-Barr virus. Effect on synthesis of virus associated antigens. Int. J. Cancer 16, 1–6 (1975)PubMedGoogle Scholar
  103. Sairenji, T., Hinuma, Y., Sekizawa, T., Yoshida, M.: Appearance of early and late components of Epstein-Barr virus associated membrane antigen in Daudi cells superinfected with P3HR-1 virus. J. Gen. Virol. 38, 111–120(1977)Google Scholar
  104. Schulte-Holthausen, H., zur Hausen, H.: Partial purification of the Epstein-Barr virus and some properties of its DNA. Virology 40, 776–779 (1970)PubMedGoogle Scholar
  105. Shamoto, M., Suzubi, I.: An immunoelectron microscopic analysis of Epstein-Barr virus associated complement fixing antigen. Cancer 38, 2057–2064 (1976)PubMedGoogle Scholar
  106. Silvestre, D., Kourilsky, F. M., Klein, G., Yata, Y., Neauport-Sautes, C, Levy, J. P.: Relationship between the EBV-associated membrane antigen on Burkitt lymphoma cells and the viral envelope demonstrated by immunoferritin labelling. Int. J. Cancer 8, 222–233 (1971)PubMedGoogle Scholar
  107. Stephens, R., Traul, K., Gandrean, P., Jeh, J., Fisher, L., Mayyasi, S. A.: Comparative studies on EBV-antigens by immunofluorescence and immunoperoxidase techniques. Int. J. Cancer 19, 305–316 (1977)PubMedGoogle Scholar
  108. Stevens, D. A., Pry, T. W., Blackham, E. A.: Prevalence of precipitating antibody to antigens derived from Burkitt lymphoma cultures infected with herpes-type virus (EB virus). Blood 35, 263–275 (1970 a)PubMedGoogle Scholar
  109. Stevens, D. A., Pry, T. W., Blackham, E. A., Manaker, R. A.: Immunodiffusion studies of EB virus (herpes-type virus)-infected and uninfected hemic cell lines. Int. J. Cancer 5, 229–237 (1970 b)PubMedGoogle Scholar
  110. Sugawara, K., Osato, T.: An immunoferritin study of a Burkitt lymphoma cell line harboring EB virus particles. Gann 61, 279 (1970).PubMedGoogle Scholar
  111. Svedmyr, A., Demissie, A., Klein, G., Clifford, P.: Antibody patterns in different human sera against intracellular and membrane antigen complexes associated with Epstein-Barr virus. J. Natl. Cancer Inst. 44, 595–610 (1970)PubMedGoogle Scholar
  112. Svedmyr, E., Jondal, M.: Cytotoxic cells specific for B cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc. Natl. Acad. Sci. USA 72, 1622–1626 (1975)PubMedGoogle Scholar
  113. Svedmyr, E., Jondal, M., Henle, W., Weiland, O., Rombo, L., Klein, G.: EBV-specific killer T cells and serologic response after onset of infectious mononucleosis. (Submitted for publication) (1978)Google Scholar
  114. Tegtmeyer, P.: Function of Simian virus 40 gene A in transforming infection. J. Virol. 15, 613–618 (1975)PubMedGoogle Scholar
  115. Vestergaard, B. F., Hesse, J., Norrild, B., Klein, G.: Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV). Int. J. Cancer 21, 323–328 (1978)PubMedGoogle Scholar
  116. Vonka, V., Benyesh-Melnick, M., Lewis, R. T., Wimberly, I.: Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines. Arch. Ges. Virusforsch. 31, 113–124 (1970)PubMedGoogle Scholar
  117. Walters, M. K., Pope, J. H.: Studies of the EB virus related antigens of human leukocyte cell lines. Int. J. Cancer 8, 32–40 (1971)PubMedGoogle Scholar
  118. Weeke, B.: Crossed Immunoelectrophoresis. A mannual of quantitative Immunoelectrophoresis. Scand. J. Immunol. Suppl 1, 47–56 (1973)PubMedGoogle Scholar
  119. Yata, J., Klein, G.: Some factors affecting membrane immunofluorescence reactivity of Burkitt lymphoma tissue culture cell lines. Int. J. Cancer 4, 767–775 (1969)PubMedGoogle Scholar
  120. Yata, J., Klein, G., Hewetson, J., Gergely, L.: Effect of metabolic inhibitors on membrane immunofluorescence reactivity of established Burkitt lymphoma cell lines. Int. J. Cancer 5, 394–403 (1970)PubMedGoogle Scholar
  121. Zajac, B. A., Ogburn, C. A.: Preparation of rabbit anti-sera to Epstein-Barr virus D-early antigens. In: Oncogenesis and herpesviruses II. de-Thé, G., Epstein, M. A., zur Hausen, H. (eds.), Part. 1, pp. 331 – 337. Lyon: IARC 1975Google Scholar
  122. zur Hausen, H., Schulte-Holthausen, H.: Presence of EB virus nucleic acid homology in a “virus-free” line of Burkitt tumour cells. Nature 227, 245–248 (1970)PubMedGoogle Scholar
  123. zur Hausen, H., Henle, W., Hummeler, K., Diel, V., Henle, G.: Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography and electron microscopy. J. Virol. 1, 830–837 (1967)PubMedGoogle Scholar
  124. zur Hausen, H., O’Neill, F. J., Freese, U. K., Hecker, E.: Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 272, 373–375 (1978)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1979

Authors and Affiliations

  • I. Ernberg
    • 1
  • G. Klein
    • 1
  1. 1.Department of Tumor BiologyKarolinska InstitutetStockholm 60Sweden

Personalised recommendations